ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 558 filers reported holding ASTRAZENECA PLC in Q3 2019. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,478,598 | -90.7% | 21,834 | -90.2% | 0.03% | -90.4% |
| Q2 2023 | $15,968,268 | -41.9% | 223,114 | -43.6% | 0.34% | -36.8% |
| Q1 2023 | $27,460,678 | +77.0% | 395,630 | +72.9% | 0.54% | +23.9% |
| Q4 2022 | $15,515,962 | +17.3% | 228,849 | -5.1% | 0.44% | +5.5% |
| Q3 2022 | $13,226,000 | +19.4% | 241,171 | +43.9% | 0.42% | +33.8% |
| Q2 2022 | $11,076,000 | -59.5% | 167,647 | -63.3% | 0.31% | -66.4% |
| Q2 2021 | $27,340,000 | +100.9% | 456,431 | +66.8% | 0.93% | +22.2% |
| Q1 2021 | $13,607,000 | +79.5% | 273,675 | +97.8% | 0.76% | +26.8% |
| Q3 2020 | $7,581,000 | +140.0% | 138,339 | +95.6% | 0.60% | +123.1% |
| Q1 2020 | $3,159,000 | -86.8% | 70,732 | -85.3% | 0.27% | -85.5% |
| Q4 2019 | $23,917,000 | +69.9% | 479,690 | +51.9% | 1.84% | +5.1% |
| Q3 2019 | $14,073,000 | – | 315,748 | – | 1.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |